Top 92 alternative sites to cariboubio.com
-
allogene.com
-
oysterpointrx.com
-
eurekatherapeutics.com
-
connectbiopharm.com
-
caladrius.com
-
tcbiopharm.com
-
khondrion.com
-
adicetbio.com
-
ocugen.com
-
tessacell.com
-
meliorpharmaceuticals.com
-
firstwavebio.com
-
renovacareinc.com
-
cellmedicine.com
-
lineagecell.com
-
helixbiopharma.com
-
regenesys.eu
-
circbiosciences.com
-
celularity.com
-
precigen.com
-
abcentra.com
-
arvinas.com
-
cellectis.com
-
rebiotix.com
-
biolinerx.com
-
dreambody.clinic
-
formatherapeutics.com
-
delpor.com
-
legendbiotech.com
-
cgoncology.com
-
chiasma.com
-
newron.com
-
immunitybio.com
-
akaalpharma.com
-
bioxcellerator.com
-
ocuphire.com
-
adaptimmune.com
-
geron.com
-
chinooktx.com
-
imv-inc.com
-
bonetherapeutics.com
-
miltenyibiomedicine.com
-
cell-innovations.com.au
-
blackthornrx.com
-
ampiopharma.com
-
cytologicsbio.com
-
stemcells21.com
-
shorelinebio.com
-
i-mabbiopharma.com
-
pharnext.com
-
cartesiantherapeutics.com
-
altimmune.com
-
spiraltx.com
-
amphera.nl
-
medicago.com
-
procella.se
-
viacyte.com
-
arcturusrx.com
-
tricida.com
-
sola-bio.com
-
actris.sg
-
proqr.com
-
aeglea.com
-
cuebiopharma.com
-
askbio.com
-
glycadia.com
-
atarabio.com
-
azurrx.com
-
zymeworks.com
-
americangene.com
-
blademed.com
-
ltcreit.com
-
iwirc.com
-
mozart-tx.com
-
g1therapeutics.com
-
eurekaconnectme.com
-
amunix.com
-
dynavax.com
-
vir.bio
-
neoleukin.com
-
plexxikon.com
-
cpii.com
-
nkartatx.com
-
corvuspharma.com
-
tempesttx.com
-
bluefieldproject.org
-
allakos.com
-
orphomed.com
-
americancollegeofbankruptcy.com
-
zosanopharma.com
-
novomedix.com
-
harpoontx.com
THE NEXT REVOLUTIONIN CELL THERAPY
A clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCART™) therapies for cancer.
Oyster Point Pharma - Therapies to Address Ophthalmic Disease
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease.
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
Caladrius Biosciences | Cell Therapy & Regenerative Medicine Development
Caladrius Biosciences (NASDAQ: CLBS) develops regenerative therapies that reverse chronic disease. Learn more about our cell therapy development and commercialization.
Home • TC BioPharm
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer.
Home - Khondrion
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Adicet Bio | Gamma Delta T cells
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
Ocugen, Inc. – Pursuing Innovative Ocular Biotherapeutics
Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Melior Pharmaceuticals | Biopharmaceutical Research & Development Company PA
Melior Pharmaceuticals is a mid-stage biopharmaceuticals company in Pennsylvania that develops therapies for diabetes and parkinson’s disease.
Home - First Wave BioPharma, Inc.
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
RenovaCare | Cell Renewal, Naturally.
RenovaCare, Inc. is a biotechnology company focused on developing autologous stem cell therapies for the regeneration of human organs.
Stem Cell Institute Panama - Stem Cell Therapy
Welcome to Stem Cell Institute Stem Cell Institute is one of the world’s leading adult stem cell therapy and research centers. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of allogeneic human umbilical cord stem cells and autologous
Author: Jaytest
Home - Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Helix BioPharma - New Directions in Cancer Therapy
We are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on our proprietary technological platform.
ReGenesys bvba
ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based therapies.
Author: Regenesys Bvba
CiRC Biosciences - CiRC Biosciences
CiRC is a privately held, cell therapy company, developing treatments for serious diseases with high, unmet needs with an initial focus on the eye.
Author: Eli Schmidt
Celularity Inc. (NASDAQ:CELU)
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Author: Celularity Inc
Other sites like cariboubio com
Home - Precigen
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
Home • Arvinas
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
Microbiota Restoration Therapy™ for Gastrointestinal Diseases | Rebiotix Inc.
A clinical stage microbiome company developing microbiota restoration therapies for the treatment of gastrointestinal diseases from gut dysbiosis.
Home | BioLineRx
BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.
Dream Body Clinic Stem Cell Therapy Stem Cells HGH
Dream Body Clinic Stem Cell Therapy and Stem Cell Treatment, Human Growth Hormone HGH Norditropin or Genotropin. Stem Cell Knee Repair
Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Delpor.com – Breakthrough Discoveries for a Better Life
News View All Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
Author: Delpor Admin
Home - Legend Biotech
Legend Biotech is a multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies with the ultimate goal of changing the way life-threatening diseases are treated.
Oncolytic immunotherapy | CG0070 | CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.
Chiasma: Empowering Lives for Everyday Living
Chiasma is a clinical-stage biopharmaceutical company dedicated to addressing the everyday challenges associated with existing therapies for rare or serious chronic diseases.
Homepage | Newron Pharmaceuticals
We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system
Immunotherapy by ImmunityBio - Cell Therapy for Cancer
ImmunityBio is dedicated to conquering cancer. We develop therapies that **** disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.
Author: Dr Patrick Soon-Shiong Executive Chairman; ImmunityBio
Akaal Pharma Pty Ltd | clinical-stage **** discovery and development
Akaal Pharma is a clinical-stage **** discovery and development company focused on developing novel drugs for the treatment of inflammatory diseases.
World Leader in Stem Cell Therapy and Immunotherapy Treatments
Top Rated stem cell therapy clinic in the world using Wharton Jelley Stem Cell Therapy to help patients with chronic back pain, Autoimmune diseases, and orthopedic injuries. Bioxcellerator located in Medellin, Colombia is the world leader in stem cell therapy.
Ocuphire Pharma, Inc. (OCUP)
Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company developing and commercializing therapies for the treatment of eye disorders.
Adaptimmune Therapeutics plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Chinook Therapeutics | Atrasentan
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
What else cariboubio.com alternative websites
IMV Inc.
IMV Inc. is a clinical-stage biopharmaceutical company developing a new class of cancer immunotherapies and vaccines against infectious diseases
A regenerative therapy company - Bone Therapeutics
Bone Therapeutics is a bone cell therapy company specializing in addressing unmet medical needs in the field of bone fracture repair and bone fracture prevention. Bone Therapeutics develops both autologous and allogeneic innovative cell therapy products.
Author: Bone Therapeutics SA
Personalized cell and gene therapy | Miltenyi Biomedicine
Miltenyi Biomedicine GmbH develops innovative cell and gene therapies. We are focused on bringing cancer treatments and regenerative therapies to patients.
SVF Cell Therapy | Australia | Cell Innovations -
Cell-Innovations
About Cell-Innovations Cell-Innovations patented technology Cell-Innovations is an Australian-owned company involved in developing and commercialising cutting-edge regenerative medical technologies. Cell-Innovations is engaged in clinical and basic science studies to test the application of autologous Stromal Vascular Fraction (SVF) for various clinical indications. Cell-Innovations has developed a portfolio of licensed technologies that deliver efficient and reliable …
Neurobehavioral Disorder **** Development | BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company developing novel, targeted treatments for neurobehavioral disorders. Learn more.
Ampio Pharmaceuticals
A development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.
Cytologics - Cell Processing and Isolation Services
Cytologics support researchers focused on **** discovery, diagnostic development and cell therapies by providing high-quality human biological material.
Author: Cytologics
Stem Cell Therapy in Bangkok - Book Now - StemCells21 - novel regenerative medicine
Stem Cell Therapy for Disease and Anti-ageing in Bangkok, Thailand. 12 years clinical regenerative medicine experience in treating patients with mesenchymal stem cell treatment.
Author: Pc Com
Home - Shoreline Biosciences
Advancing the Next Generation of iPSC-derived NK Cell and Macrophage Immunotherapies California Life Sciences awarded Kite Pharma, a Gilead company, and Shoreline Biosciences the 2021 Strategic Partnership of the Year Award Leading the Legacy of the Most Effective and Affordable Cell Therapies We develop genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer (NK) […]
I-Mab Biopharma | Bringing Transformational Medicines to Patients Through Innovation
I-Mab is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class and best-in-class biologics to treat cancers and autoimmune diseases.
Pharnext - Pharnext
Pharnext is an advanced clinical-stage biopharmaceutical company developing novel first-in-class therapies for orphan and common diseases with high unmet medical needs, leveraging our artificial intelligence (AI)-based PLEOTHERAPY™ platform.
Cartesian | Developing potent, safer cell and gene therapies for cancer and autoimmune diseases | Cartesian
Pioneering RNA-Engineered Cell Therapy In and Beyond Oncology Cartesian uses the RNA Armory®, its proprietary cell therapy platform, to engineer combination therapies into cells, and targets these cells precisely to the site of disease. UNDERSTAND OUR SCIENCE Our therapeutic candidates Cartesian
Author: Cartesian
Altimmune a clinical stage biopharmaceutical company
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Spiral Therapeutics - Therapies for Hearing Loss
Spiral is a clinical stage pharmaceutical company developing therapies that target hearing loss and other ear disorders.
Home - Amphera
Amphera B.V., a clinical stage Dutch life science company, develops dendritic cell therapies for the treatment of cancer.
Developing novel vaccines and therapeutic proteins | Medicago
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
Procella Therapeutics AB - Cell Therapy Solutions
Procella Therapeutics AB is a biotech company focused on developing cardiac stem cell technology with the aim of treating heart failure.
ViaCyte | Regenerative Medicine Therapies for Diabetes
ViaCyte is a regenerative medicine company focused on the discovery, development & commercialization of novel cell replacement therapies to treat diabetes.
Arcturus Therapeutics
Arcturus Therapeutics is a clinical-stage messenger RNA medicines company focused on development and distribution of therapeutics for rare diseases & vaccines.
Tricida | Working to Turn the Tide on Metabolic Acidosis
Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational **** candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive muscle breakdown and exacerbation of bone disease.
Other websites similar as cariboubio.com
Home -
SOLA Biosciences (Greater Boston, MA) is a pre-clinical-stage biopharmaceutical company focusing on developing transformative gene therapies to treat protein misfolding diseases. SOLA developed a proprietary “JUMP70 (J-domain Upholding Misfolding-Protein for Hsp70 Chaperone)” technology platform designed to harness the power of a patient’s own chaperones to repair disease-causing proteins. SOLA is currently developing eight (8) pipeline … Continue reading "Home"
Cell Therapy Manufacturing and Process Development
Advanced Cell Therapy and Research Institute Singapore facilitates discovery, process development and manufacturing of cellular-based therapeutics. Our goal is to promote and foster the entire value chain of the cellular ecosystem through translational research and development. Visit us today.
ProQR Therapeutics - Striving to reverse blindness
ProQR is a clinical stage biotech company that discovers and develops unique RNA therapies for severe genetic disorders, specialized in retinal diseases.
Aeglea BioTherapeutics | Rare Metabolic Disease | Home
Aeglea BioTherapeutics is a clinical stage company developing enzyme therapies for rare metabolic diseases like Arginase 1 Deficiency and Homocystinuria.
Immune Responses, On Cue - Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) is designed to harness the body’s intrinsic […]
AskBio - AAV Gene Therapy Technology & Therapeutics
AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic and complex disorders. Learn more about our gene therapy technology and current clinical trials.
Glycadia Pharmaceuticals – Glycadia Pharmaceuticals
Commitment to Discovery Glycadia is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular and related diseases that result from diabetes. Learn More Focus and Market The current approach to
Author: Gp J
Atara Bio - Home
Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases.Leveraging our novel allogeneic EBV T-cell platform, Atara intends to deliver treatments to patients with high unmet medical need. Our platform aims to leverage the unique biology of EBV T cells to channel the power of the immune system and has the potential to...
Author: August
AzurRx BioPharma
AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. Our therapeutic products will be administered to patients as **** non-systemic biologics.
Zymeworks
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
American Gene Technologies: Developing Gene And Cell Therapies
American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. AGT expects its lead candidate for an **** cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers.
Some websites with similar theme to cariboubio.com include:
Blade Therapeutics
Blade Therapeutics is advancing innovative anti-fibrotic therapies to meet currently unserved patient needs.
Financing Senior Housing Since 1992 | LTC Properties Inc.
LTC Properties is a REIT investing in seniors housing and health care through sale-leasebacks, mortgage financing, joint-ventures, construction financing and structured finance solutions.
IWIRC, International Women's Insolvency & Restructuring Confederation
IWIRC, the premier networking organization for women in the practice of insolvency and restructuring, helps its members achieve productive relationships by providing a range of practice development and networking opportunities that enhance their professional stature within an open and friendly culture.
Mozart Therapeutics | CD8 T regulatory cells | Autoimmune and Inflammatory diseases
Mozart Therapeutics is capitalizing on a novel CD8 T regulatory cell network to develop innovative disease-modifying therapies for autoimmune and inflammatory diseases.
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
Liver Cancer & T-Cell Therapy | Eureka Connect Me
Learn more about liver cancer and our unique approach to tackling liver cancer at Eureka Connect Me.
XPAT® | Pro-XTEN Platform | T Cell Engagers | Amunix Pharmaceuticals
Amunix is an immuno-oncology company leveraging Pro-XTEN technology platform to discover and develop transformative therapies for patients with cancer.
Dynavax Technologies | Toll-like Receptor | Vaccines
Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
Vir Biotechnology
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
More other alternatives for cariboubio com
The Protein Design Revolution Begins Here
Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and autoimmunity.
Engineering Drugs for Personalized Medicines
Engineering Drugs for Personalized Medicines, Plexxikon has earned a reputation as a leader in targeted **** discovery and translational, personalized medicine.
Communications & Power Industries
Communications & Power Industries (CPI) provides microwave, radio frequency (RF), power and control solutions for defense, communications, medical, scientific and industrial applications. Products include: VEDs, klystrons, TWTs, TWTAs, CFAs, satcom amplifiers, HPAs, SSPAs, LNAs, LNBs, power grid devices, advanced antenna systems, BUCs, solid-state devices, IMAs, EIKs, magnetrons, gyrotrons, medical x-ray generators, medical digital imaging systems, telemetry systems, radomes, transmitters, microwave switches, RF decks, receiver protectors, pressure windows, helix devices, coupled cavity devices
Natural Killer Cells (NK Cells) for the treatment of cancer
Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.
Bringing ingenuity to drugdevelopment
Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
Innovative Targeted and Immune-Mediated Cancer Therapies
Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.
Frontotemporal dementia | The Bluefield Project to Cure FTD
The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). FTD is a devastating, early-onset degenerative brain disease and is recognized as a common cause of dementia in people under the age of 60 years.
Allakos | AK002 mAb
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
American College of Bankruptcy
The mission of the College is to honor and recognize distinguished bankruptcy professionals who are qualified for membership in an effort to set standards of achievement for others in the insolvency community.
Zosano Pharma | Migraine treatment | M207 | zolmitriptan
Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy.
NovoMedix LLC
NovoMedix is conquering Cancer and Fibrosis by IL-11 inhibition and modulation of key regulatory pathways
Harpoon Therapeutics | Immuno-oncology | TriTAC™
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
